drugset / Trial / NCT02227446

Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (VANCO)

NCT02227446

Phase 3 Completed 1036 enrolled Major Extremity Trauma Research Consortium
RandomizedParallel-groupOpen-labelTreatment

Summary

The Vancomycin Study is a multi-center, prospective randomized controlled trial that will compare the proportion of deep surgical site infections within 6 months in patients treated with local Vancomycin powder compared to those treated without local Vancomycin powder at the time of fracture fixation.

Timeline

Start
2014-10
Primary completion
2018-06
Completion
2019-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Vancomycin Other / unclassified 1000 mg Other

Indications

No indication recorded.